Metalmark’s investment in Collagen Matrix will provide the resources, expertise and capital needed to continue to grow the business. As part of the transaction, the company’s management team, including founder, Shu-Tung Li, PhD, will remain with the company. Financial terms were not disclosed.
Collagen Matrix focuses on the design and engineering of collagen-and mineral-based extracellular matrices for tissue and organ repair and regeneration. Its products include OssiMend Bone Graft Matrix and DuraMatrix-Onlay Conformable Collagen Dura Substitute Membrane.
More articles on devices:
10 trends in the growing orthobiologics device market
U.S. Army’s Telemedicine & Advanced Technology Research Center awards $2.1M to Teleflex
A new powerhouse in the extremities market? 8 things to know about the Wright Medical Group-Tornier merger
